Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Parallel Arm Study to Evaluate the Safety, Tolerability, and Effect on Atrial Fibrillation Burden of BMS-919373 in Patients With Paroxysmal Atrial Fibrillation
Conditions
Interventions
BMS-919373
Placebo (Matching with BMS-919373)
Locations
35
United States
Cardiology Consultants Of Orange County Med. Group Inc
Anaheim, California, United States
Oracle Clinical Research, Inc.
Anaheim, California, United States
Wcct Global, Llc
Costa Mesa, California, United States
Long Beach Va Medical Center
Long Beach, California, United States
Spectrum Clinical Research
Moreno Valley, California, United States
Chase Medical Research, Llc
Waterbury, Connecticut, United States
Start Date
July 25, 2014
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
July 31, 2019
NCT07281898
NCT06765356
NCT06106594
NCT05172765
NCT06431815
NCT05462145
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions